Jump to content

Johann Bauersachs

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Citation bot (talk | contribs) at 17:15, 21 July 2022 (Add: hdl. | Use this bot. Report bugs. | Suggested by BrownHairedGirl | #UCB_webform 1203/3674). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Johann Bauersachs
Born (1966-04-22) 22 April 1966 (age 58)
Karlsruhe
NationalityGerman
Known foracute coronary syndrome, left ventricular healing and remodeling after ischemia as well as acute and chronic heart failure.
Scientific career
Fieldsinternal medicine, cardiology, intensive care
InstitutionsHannover Medical School

Prof. Dr. Johann Bauersachs is a German internist, cardiologist, and full professor at the Hannover Medical School.[1] He is widely recognized for his scholarly contributions to the domains of acute coronary syndrome, left ventricular repair and remodelling following ischemia, and acute and chronic heart failure.[2][3][4][5][6]

Education

Prof. Dr. Johann Bauersachs was born in Karlsruhe on April 22, 1966. He studied medicine at Freiburg University.[7] After completing clinical and research fellowships at the Universities of Frankfurt, Heidelberg/Manheim and Wuerzburg, . He was appointed as consultant and Lecturer in Internal Medicine and Cardiology at the University Hospital Wuerzburg.[8]

Scientific Contributions

His research interests include the pathogenesis and therapy of peripartum cardiomyopathy, as well as in the mechanisms mediated by aldosterone and mineralocorticoid receptors and the involvement of non-coding RNAs.[9][10][11][12] Dr. Johann Bauersachs is a full professor of cardiology and the head of the department at Hannover Medical School (MHH) in Germany.[13]

  • Novel antisense therapy targeting microRNA -132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study.[14]
  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.[15]
  • Heart failure drug treatment: the fantastic four.[16]

Memberships & Awards

Dr. Johann Bauersachs was awarded the Oskar-Lapp Award (2001) and the Albert-Fraenkel-Award (2004) from the German cardiac Society.[17] In 20018, he received the Paul-Morawitz Award from the same society.[18] Also, in the year 2006, he received the Parmley-Award from the American college of cardiology.[19] His additional awards include the Bernard and Joan Marshall Distinguished Investigator Award (2012). He served as a President of ESAC Germany (European Section of Aldosterone Council) Association.

Professor Bauersachs is a Fellow of the American Heart Association, the European Society of Cardiology (ESC), and the European Society of Cardiology's Heart Failure Association (HFA).[20]

Publications

  • The struggle towards a Universal Definition of Heart Failure-how to proceed?[21]
  • Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction.[22]
  • Risk stratification and management of women with cardiomyopathy / heart failure planning pregnancy or presenting during / after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy.[23]

References

  1. ^ "Medizinische Hochschule Hannover : Department of Cardiology und Angiology". www.mhh.de. Retrieved 2022-03-22.
  2. ^ Harjola, Veli‐Pekka; Parissis, John; Bauersachs, Johann; Brunner‐La Rocca, Hans‐Peter; Bueno, Hector; Čelutkienė, Jelena; Chioncel, Ovidiu; Coats, Andrew J.S.; Collins, Sean P.; Boer, Rudolf A.; Filippatos, Gerasimos (2020-04-29). "Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology". European Journal of Heart Failure. 22 (8): 1298–1314. doi:10.1002/ejhf.1831. ISSN 1388-9842. PMID 32347648. S2CID 216647317.
  3. ^ Collet, Jean-Philippe; Thiele, Holger; Barbato, Emanuele; Barthélémy, Olivier; Bauersachs, Johann; Bhatt, Deepak L.; Dendale, Paul; Dorobantu, Maria; Edvardsen, Thor; Folliguet, Thierry; Gale, Chris P. (2021-04-07). "2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation". European Heart Journal. 42 (14): 1289–1367. doi:10.1093/eurheartj/ehaa575. ISSN 1522-9645. PMID 32860058.
  4. ^ Schäfer, Andreas; Bauersachs, Johann (2021-11-03). "P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention – Understanding the debate on Prasugrel or Ticagrelor". Pharmacology & Therapeutics. 233: 108029. doi:10.1016/j.pharmthera.2021.108029. ISSN 0163-7258. PMID 34740747. S2CID 243483077.
  5. ^ Harjola, Veli-Pekka; Parissis, John; Bauersachs, Johann; Rocca, Hans-Peter Brunner-La; Bueno, Hector; Celutkiene, Jelena; Chioncel, Ovidiu; Coats, Andrew J. S.; Collins, Sean P.; Boer, Rudolf A. de; Filippatos, Gerasimos (2020-08-01). "Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology". European Journal of Heart Failure. 22 (8): 1298–1314. doi:10.1002/ejhf.1831. ISSN 1388-9842. PMID 32347648. S2CID 216647317.
  6. ^ Harjola, Veli Pekka; Parissis, John; Bauersachs, Johann; Rocca, Hans Peter Brunner-La; Bueno, Hector; Čelutkienė, Jelena; Chioncel, Ovidiu; Coats, Andrew J. S.; Collins, Sean P.; Boer, Rudolf A. de; Filippatos, Gerasimos (2020-04-29). "Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology". European Journal of Heart Failure. 22 (8): 1298–1314. doi:10.1002/ejhf.1831. ISSN 1388-9842. PMID 32347648. S2CID 216647317.
  7. ^ Coats, Andrew J.S. (May 2019). "Figures of the Heart Failure Association: Professor Dr. med. Johann Bauersachs, Chair of the Clinical Science Section". European Journal of Heart Failure. 21 (5): 545–548. doi:10.1002/ejhf.1484. ISSN 1388-9842. PMID 31069912. S2CID 148570940.
  8. ^ Coats, Andrew J.S. (May 2019). "Figures of the Heart Failure Association: Professor Dr. med. Johann Bauersachs, Chair of the Clinical Science Section". European Journal of Heart Failure. 21 (5): 545–548. doi:10.1002/ejhf.1484. ISSN 1388-9842. PMID 31069912. S2CID 148570940.
  9. ^ Hilfiker-Kleiner, Denise; Haghikia, Arash; Nonhoff, Justus; Bauersachs, Johann (2015-05-07). "Peripartum cardiomyopathy: current management and future perspectives". European Heart Journal. 36 (18): 1090–1097. doi:10.1093/eurheartj/ehv009. ISSN 0195-668X. PMC 4422973. PMID 25636745.
  10. ^ Bauersachs, Johann; König, Tobias; van der Meer, Peter; Petrie, Mark C.; Hilfiker-Kleiner, Denise; Mbakwem, Amam; Hamdan, Righab; Jackson, Alice M.; Forsyth, Paul; de Boer, Rudolf A.; Mueller, Christian (July 2019). "Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy". European Journal of Heart Failure. 21 (7): 827–843. doi:10.1002/ejhf.1493. hdl:10044/1/71400. ISSN 1879-0844. PMID 31243866. S2CID 195696779.
  11. ^ Bauersachs, Johann; Jaisser, Frédéric; Toto, Robert (2015-02-01). "Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases". Hypertension. 65 (2): 257–263. doi:10.1161/HYPERTENSIONAHA.114.04488. PMID 25368026. S2CID 12941494.
  12. ^ Güder, Gülmisal; Bauersachs, Johann; Frantz, Stefan; Weismann, Dirk; Allolio, Bruno; Ertl, Georg; Angermann, Christiane E.; Störk, Stefan (2007-04-03). "Complementary and Incremental Mortality Risk Prediction by Cortisol and Aldosterone in Chronic Heart Failure". Circulation. 115 (13): 1754–1761. doi:10.1161/CIRCULATIONAHA.106.653964. PMID 17372171. S2CID 12663535.
  13. ^ www.medifind.com https://www.medifind.com/conditions/peripartum-cardiomyopathy/4180/doctors/johann-bauersachs/210805226. Retrieved 2022-03-22. {{cite web}}: Missing or empty |title= (help)
  14. ^ Täubel, Jörg; Hauke, Wilfried; Rump, Steffen; Viereck, Janika; Batkai, Sandor; Poetzsch, Jenny; Rode, Laura; Weigt, Henning; Genschel, Celina; Lorch, Ulrike; Theek, Carmen (2021-01-07). "Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study". European Heart Journal. 42 (2): 178–188. doi:10.1093/eurheartj/ehaa898. ISSN 0195-668X. PMC 7954267. PMID 33245749.
  15. ^ Collet, Jean-Philippe; Thiele, Holger; Barbato, Emanuele; Barthélémy, Olivier; Bauersachs, Johann; Bhatt, Deepak L; Dendale, Paul; Dorobantu, Maria; Edvardsen, Thor; Folliguet, Thierry; Gale, Chris P (2021-04-07). "2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation". European Heart Journal. 42 (14): 1289–1367. doi:10.1093/eurheartj/ehaa575. ISSN 0195-668X. PMID 32860058.
  16. ^ Bauersachs, Johann (2021-02-11). "Heart failure drug treatment: the fantastic four". European Heart Journal. 42 (6): 681–683. doi:10.1093/eurheartj/ehaa1012. ISSN 0195-668X. PMC 7878007. PMID 33447845.
  17. ^ "Oskar-Lapp-Forschungspreis" (in German). Retrieved 2022-03-22.
  18. ^ Eschenhagen, Thomas (2018-08-21). "From basic science to high performance medicine". European Heart Journal. 39 (32): 2919–2921. doi:10.1093/eurheartj/ehy425. ISSN 0195-668X. PMID 30165623.
  19. ^ "circulation.inforang.com" (PDF).
  20. ^ "European Heart Journal Team Heart Failure". European Heart Journal. 42 (31): 2968. 2021-08-14. doi:10.1093/eurheartj/ehab284. ISSN 0195-668X. PMID 34219156.
  21. ^ Cleland, John G F; Pfeffer, Marc A; Clark, Andrew L; Januzzi, James L; McMurray, John J V; Mueller, Christian; Pellicori, Pierpaolo; Richards, Mark; Teerlink, John R; Zannad, Faiez; Bauersachs, Johann (2021-06-21). "The struggle towards a Universal Definition of Heart Failure—how to proceed?". European Heart Journal. 42 (24): 2331–2343. doi:10.1093/eurheartj/ehab082. ISSN 0195-668X. PMID 33791787.
  22. ^ Diekmann, Johanna; Koenig, Tobias; Zwadlo, Carolin; Derlin, Thorsten; Neuser, Jonas; Thackeray, James T.; Schäfer, Andreas; Ross, Tobias L.; Bauersachs, Johann; Bengel, Frank M. (April 2021). "Molecular Imaging Identifies Fibroblast Activation Beyond the Infarct Region After Acute Myocardial Infarction". Journal of the American College of Cardiology. 77 (14): 1835–1837. doi:10.1016/j.jacc.2021.02.019. PMID 33832609. S2CID 233193875.
  23. ^ Sliwa, Karen; Meer, Peter; Petrie, Mark C.; Frogoudaki, Alexandra; Johnson, Mark R.; Hilfiker‐Kleiner, Denise; Hamdan, Righab; Jackson, Alice M.; Ibrahim, Bassem; Mbakwem, Amam; Tschöpe, Carsten (April 2021). "Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy". European Journal of Heart Failure. 23 (4): 527–540. doi:10.1002/ejhf.2133. ISSN 1388-9842. PMID 33609068. S2CID 231969561.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Johann_Bauersachs&oldid=1099604874"